BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36557969)

  • 1. Docetaxel Loaded in Copaiba Oil-Nanostructured Lipid Carriers as a Promising DDS for Breast Cancer Treatment.
    Carvalho FV; Ribeiro LNM; Moura LD; Rodrigues da Silva GH; Mitsutake H; Mendonça TC; Geronimo G; Breitkreitz MC; de Paula E
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
    Di Filippo LD; Lobato Duarte J; Hofstätter Azambuja J; Isler Mancuso R; Tavares Luiz M; Hugo Sousa Araújo V; Delbone Figueiredo I; Barretto-de-Souza L; Miguel Sábio R; Sasso-Cerri E; Martins Baviera A; Crestani CC; Teresinha Ollala Saad S; Chorilli M
    Int J Pharm; 2022 Apr; 618():121682. PubMed ID: 35307470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.
    Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Jaji AZ; Isa T; Mahmood SK; Zakaria MZAB
    Pharm Res; 2017 Jun; 34(6):1193-1203. PubMed ID: 28382563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
    Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
    Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
    Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
    Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An industrially viable technique for fabrication of docetaxel NLCs for oncotherapy.
    Kharkar PB; Talkar SS; Patravale VB
    Int J Pharm; 2020 Mar; 577():119082. PubMed ID: 31988031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma.
    de Moura LD; Ribeiro LNM; de Carvalho FV; Rodrigues da Silva GH; Lima Fernandes PC; Brunetto SQ; Ramos CD; Velloso LA; de Araújo DR; de Paula E
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel Loaded Pomegranate Seed Oil Based Nanostructured Lipid Carriers: A Potential Alternative to Current Formulation.
    Talkar SS; Kharkar PB; Patravale VB
    AAPS PharmSciTech; 2020 Oct; 21(8):295. PubMed ID: 33099708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication, optimization, and
    Mathur P; Sharma S; Rawal S; Patel B; Patel MM
    J Liposome Res; 2020 Jun; 30(2):182-196. PubMed ID: 31060404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
    Rarokar NR; Khedekar PB; Bharne AP; Umekar MJ
    Int J Biol Macromol; 2019 Mar; 125():1056-1068. PubMed ID: 30572051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
    Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
    Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.
    Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK
    J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.